VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AEHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AEHRAehr Test Systems
$53.57$1.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAEHRFinancials

Aehr Test Systems (AEHR) Income Statement

30Y historyFree accessUpdated daily

Revenue and margins have swung sharply, with operating margin moving from -49.2% in 2026Q2 to +18.3% in 2027Q1, but this trajectory appears driven by lumpy order volume rather than a steady compounding trend.

Income StatementBalance SheetCash FlowRatios

AEHR Income Statement

Annual statement

AEHR Income Statement

Aehr Test Systems (AEHR) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMMay'26May'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97
Sales/Revenue72.95M50M58.97M66.22M64.96M50.83M16.6M22.29M21.06M29.55M18.9M14.5M10.02M19.68M16.49M15.52M13.74M11.67M21.41M39.04M27.35M23.8M16.08M15.8M15.09M12.57M31.04M24.5M18.15M40.8M42M
Revenue Growth %28.4%-15.21%-10.95%1.93%27.8%206.2%-25.53%5.87%-28.76%56.39%30.32%44.75%-49.11%19.38%6.23%12.99%17.67%-45.47%-45.17%42.74%14.92%48.02%1.77%4.69%20.08%-59.51%26.66%35.04%-55.53%-2.85%-
Cost of Goods Sold43.36M32.35M35.03M33.67M32.22M27.16M10.57M13.92M13.45M17.17M12.12M9.36M6.18M9.46M9.71M9.31M8.22M5.57M19.82M19.07M13.44M13.16M11.82M10.09M9.35M6.49M17.92M17.27M12.2M24.36M25.1M
COGS % of Revenue-64.7%59.41%50.85%49.59%53.44%63.66%62.45%63.9%58.09%64.12%64.52%61.69%48.07%58.9%60.01%59.87%47.72%92.6%48.85%49.13%55.31%73.49%63.87%61.98%51.62%57.74%70.46%67.24%59.7%59.76%
Gross Profit29.59M17.65M23.93M32.54M32.75M23.66M6.03M8.37M7.6M12.39M6.78M5.14M3.84M10.22M6.78M6.21M5.51M6.1M1.18M19.97M13.91M10.64M4.26M5.71M5.74M6.08M13.12M7.24M5.95M16.45M16.9M
Gross Margin %40.57%35.3%40.59%49.15%50.41%46.56%36.34%37.55%36.1%41.91%35.88%35.48%38.31%51.93%41.1%39.99%40.13%52.28%5.53%51.15%50.87%44.69%26.51%36.13%38.02%48.38%42.26%29.54%32.76%40.3%40.24%
Gross Profit Growth %--26.25%-26.46%-0.62%38.37%292.32%-27.94%10.12%-38.62%82.68%31.78%34.05%-62.45%50.86%9.17%12.61%-9.68%415.46%-94.07%43.53%30.81%149.5%-25.32%-0.52%-5.63%-53.64%81.21%21.75%-63.85%-2.69%-
Operating Expenses33.63M31.8M28.25M22.46M19.37M15.87M10.21M10.92M11.88M11.47M11.71M11.3M10.53M9.72M10.08M10.71M10.53M10.85M26.39M14.16M12.86M10.18M9.24M10.22M10.46M10.58M11.64M12.43M10.58M12.25M13.2M
OpEx % of Revenue-63.6%47.9%33.93%29.82%31.21%61.53%48.97%56.41%38.81%61.96%77.92%105.13%49.41%61.15%69.03%76.66%92.96%123.25%36.26%47.03%42.78%57.45%64.66%69.32%84.21%37.51%50.73%58.29%30.01%31.43%
Selling, General & Admin19.92M19.16M17.78M13.75M12.24M10.05M6.56M7.53M7.72M7.29M7.05M6.97M6.47M6.32M6.87M6.53M5.96M6.09M20.62M7.66M6.54M5.84M5.21M5.57M5.92M6.55M7.26M7.93M6.89M8.62M8.9M
SG&A % of Revenue-38.32%30.16%20.76%18.84%19.77%39.53%33.78%36.68%24.67%37.32%48.1%64.58%32.12%41.68%42.05%43.42%52.2%96.34%19.61%23.9%24.55%32.43%35.27%39.22%52.09%23.4%32.36%37.98%21.12%21.19%
Research & Development13.93M12.63M10.46M8.72M7.13M5.82M3.65M3.39M4.15M4.18M4.66M4.32M4.06M3.4M3.21M4.19M4.57M4.76M5.76M6.5M6.32M4.34M4.02M4.64M4.54M4.04M4.38M4.5M3.69M3.63M3.7M
R&D % of Revenue-25.27%17.74%13.17%10.98%11.45%22%15.19%19.72%14.15%24.64%29.82%40.55%17.28%19.47%26.98%33.25%40.76%26.92%16.65%23.12%18.23%25.02%29.4%30.1%32.11%14.12%18.37%20.31%8.89%8.81%
Other Operating Expenses-213K6K0000000000000000000000000000600K
Operating Income-4.04M-14.15M-4.31M10.08M13.38M7.8M-4.18M-2.54M-4.28M915K-4.93M-6.15M-6.69M497K-3.31M-4.51M-5.02M-4.75M-24.8M5.81M1.05M455K-4.97M-4.51M-4.72M-4.5M1.47M-5.19M-4.63M4.2M3.7M
Operating Margin %-5.54%-28.3%-7.31%15.22%20.59%15.35%-25.19%-11.42%-20.3%3.1%-26.08%-42.44%-66.82%2.52%-20.06%-29.04%-36.54%-40.68%-115.85%14.88%3.84%1.91%-30.94%-28.54%-31.3%-35.83%4.74%-21.19%-25.53%10.29%8.81%
Operating Income Growth %--228.05%-142.8%-24.65%71.47%286.51%-64.32%40.47%-567.21%118.56%19.91%8.07%-1446.88%115.03%26.63%10.2%-5.69%80.85%-526.79%452.9%130.99%109.15%-10.33%4.55%-4.91%-405.91%128.35%-12.11%-210.31%13.49%-
EBITDA-4.26M-11.74M-925K11.44M13.82M8.11M-3.87M-2.16M-3.84M1.33M-4.66M-5.95M-6.56M638K-2.98M-4.02M-4.45M-4.06M-24.16M6.29M1.37M795K-4.65M-4.13M-4.14M-3.84M2.12M-4.49M-4.18M4.68M4.3M
EBITDA Margin %-5.84%-23.47%-1.57%17.28%21.28%15.95%-23.33%-9.69%-18.26%4.51%-24.65%-41.04%-65.47%3.24%-18.1%-25.87%-32.37%-34.77%-112.85%16.1%5.02%3.34%-28.93%-26.11%-27.45%-30.56%6.84%-18.32%-23.03%11.46%10.24%
EBITDA Growth %19.59%-1168.76%-108.09%-17.24%70.53%309.38%-79.18%43.78%-388.59%128.6%21.73%9.27%-1128.06%121.37%25.67%9.67%-9.53%83.2%-484.36%357.42%72.83%117.09%-12.78%0.41%-7.84%-280.92%147.28%-7.44%-189.33%8.79%-
D&A (Non-Cash Add-back)-215K03.39M1.36M450K307K310K384K431K417K271K203K135K141K322K491K573K690K644K474K323K340K323K384K582K662K651K703K453K479K600K
EBIT-962K-11.74M-4.29M12.46M14.62M9.54M-2.16M-2.77M-4.96M854K-4.95M-6.17M-6.48M433K-3.34M-3.4M-3.42M-620K-25.06M5.97M2.5M789K-4.73M-4.51M-4.72M-4.5M1.47M-5.19M-4.63M4.2M3.68M
Net Interest Income2.08M1.36M1.4M2.39M1.25M13K-46K10K-252K-399K-678K-605K-130K-26K-49K-4K3K5K142K231K1.43M374K155K00000000
Interest Income2.08M1.36M1.4M2.39M1.25M13K010K000000003K5K142K231K1.43M374K155K00000000
Interest Expense00000046K0252K399K678K605K130K26K49K4K000000000000000
Other Income/Expense2.06M2.41M22K2.38M1.24M1.74M1.98M-221K-933K-460K-699K-621K81K-90K-82K1.1M1.6M4.13M-255K160K1.45M334K241K626K106K477K1.06M1.47M1.63M540K-1.14M
Pretax Income-1.98M-11.74M-4.29M12.46M14.62M9.54M-2.2M-2.77M-5.21M455K-5.63M-6.78M-6.61M407K-3.39M-3.4M-3.42M-620K-25.06M5.97M2.5M789K-4.73M-3.88M-4.62M-4.03M2.53M-3.72M-3.01M4.74M2.6M
Pretax Margin %-2.71%-23.47%-7.28%18.81%22.5%18.77%-13.28%-12.41%-24.73%1.54%-29.78%-46.72%-66.01%2.07%-20.55%-21.93%-24.91%-5.31%-117.05%15.29%9.15%3.31%-29.44%-24.58%-30.6%-32.03%8.16%-15.18%-16.57%11.61%6.19%
Income Tax-4.12M-4.61M-381K-20.7M60K91K-177K36K27K-73K25K10K34K-15K30K-15K-49K-139K4.92M-4.6M75K-21K136K76K-74K1.24M1.05M-1.12M-677K2.33M-700K
Effective Tax Rate %208.08%39.28%8.88%-166.14%0.41%0.95%8.03%-1.3%-0.52%-16.04%-0.44%-0.15%-0.51%-3.69%-0.89%0.44%1.43%22.42%-19.62%-77.07%3%-2.66%-2.87%-1.96%1.6%-30.82%41.28%29.99%22.51%49.25%-26.92%
Net Income2.14M-7.13M-3.91M33.16M14.56M9.45M-2.03M-2.8M-5.24M528K-5.65M-6.79M-6.65M422K-3.42M-3.39M-3.37M-481K-29.97M10.57M2.43M810K-4.87M-3.96M-4.54M-5.27M-141K-2.6M-2.33M2.4M3.3M
Net Margin %2.93%-14.25%-6.63%50.07%22.41%18.59%-12.21%-12.57%-24.86%1.79%-29.91%-46.79%-66.35%2.14%-20.74%-21.83%-24.55%-4.12%-140.01%27.08%8.88%3.4%-30.29%-25.06%-30.11%-41.91%-0.45%-10.63%-12.84%5.89%7.86%
Net Income Growth %132.15%-82.25%-111.79%127.77%54.04%566.21%27.66%46.48%-1091.48%109.34%16.68%-2.08%-1675.12%112.34%-0.89%-0.47%-601.25%98.4%-383.47%335.46%199.75%116.63%-23.01%12.87%13.73%-3635.46%94.59%-11.8%-196.88%-27.12%-
Net Income (Continuing)2.14M-7.13M-3.91M33.16M14.56M9.45M-2.03M-2.8M-5.24M528K-5.65M-6.79M-6.65M422K-3.42M-3.39M-3.37M-481K-29.97M10.57M2.43M810K-4.87M-3.96M-4.54M-5.27M1.49M-2.6M-2.33M2.4M3.31M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000-21K-19K-20K-19K-20K-18K-21K-20K0000000000000000
EPS (Diluted)0.06-0.23-0.131.120.500.34-0.09-0.12-0.230.02-0.35-0.52-0.550.04-0.36-0.38-0.38-0.06-3.551.240.300.11-0.66-0.55-0.63-0.74-0.02-0.38-0.340.360.74
EPS Growth %122.23%-76.92%-111.61%124%47.06%493.52%28%48.67%-1269%105.71%32.69%5.45%-1475%111.11%5.26%0%-533.33%98.31%-386.29%313.33%172.73%116.67%-20%12.7%14.86%-3675.51%94.84%-11.76%-194.44%-51.35%-
EPS (Basic)--0.23-0.131.150.520.36-0.09-0.12-0.230.02-0.35-0.52-0.550.04-0.36-0.38-0.38-0.06-3.551.320.310.11-0.66-0.55-0.63-0.74-0.02-0.38-0.340.380.77
Diluted Shares Outstanding33.52M30.67M29.58M29.62M29.21M27.77M23.46M22.88M22.39M22.78M16.27M13.09M12.05M11.89M9.55M9.02M8.78M8.56M8.44M8.51M8.22M7.61M7.42M7.25M7.16M7.15M7.18M6.81M6.85M6.76M4.5M
Basic Shares Outstanding32.62M30.67M29.58M28.82M27.79M26.01M23.46M22.88M22.39M21.73M16.27M13.09M12.05M10.88M9.55M9.02M8.78M8.56M8.44M8.01M7.75M7.51M7.42M7.25M7.16M7.15M7.07M6.81M6.85M6.33M4.3M
Dividend Payout Ratio-------------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Volatile demand and losses

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Revenue Rebounds Sharply from Trough

According to the reported quarterly income statements, AEHR revenue rose from $9.9M in 2026Q2 to $33.0M in 2027Q1, a sequential rebound that suggests lumpy, order-driven demand rather than a steady compounding trend across the ten-quarter window.

The revenue series swings widely between roughly $10M and $33M, which points to a business dependent on episodic capital equipment orders from semiconductor test customers. The 2027Q1 spike is the strongest quarter in the dataset, but a single quarter of elevated revenue does not by itself establish durability, and investors should monitor whether subsequent quarters hold near this level. Year-over-year growth figures are volatile in both directions, reinforcing that the trajectory is cyclical rather than structurally accelerating.

Gross Margin Recovers Toward Historical Highs

As reflected in reported figures, AEHR gross margin climbed from 25.7% in 2026Q2 to 47.5% in 2027Q1, approaching the 50-54% levels seen in 2024Q4 and 2025Q1, which suggests volume leverage on fixed manufacturing costs.

The margin swing tracks revenue closely, indicating that a large share of cost of revenue behaves as fixed overhead rather than variable input cost. Recovery toward prior peak margins is encouraging, yet the magnitude of the swing implies limited pricing power that would otherwise cushion weak-volume quarters. Investors should treat the 2027Q1 margin as contingent on sustained shipment volume rather than as a new structural baseline.

Operating Losses Narrow Only on Volume

Based on the reported operating figures, AEHR operating margin moved from -49.2% in 2026Q2 to +18.3% in 2027Q1, showing operating income scaling faster than revenue only when sales volume rose meaningfully.

Operating expenses of roughly $7-10M per quarter, combining R&D and SG&A, remained relatively flat across the period, so the profitability swing is largely a function of revenue absorbing a fixed cost base. This creates high operating leverage in both directions, meaning modest revenue shortfalls can return the company to deep losses. The cost base has not visibly shrunk during the downturn, which warrants further investigation into whether spending discipline is maintained when volumes weaken.

Net Income Inflated by 2024 Gain

According to the reported income statement, AEHR posted $23.9M of net income in 2024Q4 on only $2.5M of operating income, a gap that suggests a large non-operating or tax-related item rather than core operating performance.

The disconnect between operating income and net income in 2024Q4 is too large to attribute to ordinary operations, implying non-operating gains or tax benefits that should be examined in the filing footnotes. Reported EPS in that quarter therefore overstates the underlying earning power of the business. Excluding this period, net income has been negative in most remaining quarters, so earnings quality should be assessed on operating results instead.

Recovery May Prove Another Cyclical Peak

Based on the reported quarterly figures, AEHR's sharp 2027Q1 rebound follows multiple quarters of losses, and a bear case would argue it reflects a temporary order surge rather than a sustained demand recovery.

Operating losses persisted across most of the ten quarters, and the single profitable quarter of 2027Q1 is the only recent evidence of a return to profitability. A short-seller view would emphasize that the margin recovery depends on one quarter of elevated revenue, and that a reversion to the $10M revenue level would restore losses near -40% operating margin. Investors should monitor whether order flow sustains revenue above the $20M range before extrapolating the recent improvement.

AEHR — Frequently Asked Questions

Quick answers to the most common questions about buying AEHR stock.

What was Aehr Test Systems's (AEHR) revenue in 2026?

For fiscal year 2026, Aehr Test Systems (AEHR) reported total revenue of $50.0M. This represents a 19.1% increase compared to $42.0M in 1997.

Is Aehr Test Systems (AEHR) profitable?

Aehr Test Systems (AEHR) reported a net loss of $7.1M for the fiscal year ending 2026.

What is Aehr Test Systems's operating profit margin?

Aehr Test Systems (AEHR) reported an operating income of $-14.1M, resulting in an operating profit margin of -28.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Aehr Test Systems's gross profit and gross margin?

Aehr Test Systems (AEHR) generated $17.7M in gross profit for the year, representing a gross profit margin of 35.3%. This demonstrates the company's core pricing power and production efficiency.